The Role of p53 in Metabolic Regulation
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
The metabolic changes that occur in a cancer cell have been studied for a few decades, but our appreciation of the complexity and importance of those changes is now being realized. The metabolic switch from oxidative phosphorylation to aerobic glycolysis provides intermediates for cell growth and division and is regulated by both oncogenes and tumor suppressor genes. The p53 tumor suppressor gene has long been shown to play key roles in responding to DNA damage, hypoxia, and oncogenic activation. However, now p53 has added the ability to mediate metabolic changes in cells through the regulation of energy metabolism and oxidative stress to its repertoire of activities. It is therefore the focus of this review to discuss the metabolic pathways regulated by p53 and their cooperation in controlling cancer cell metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to stopping senescent cell proliferation, p53 and RB mediate senescence-related metabolic changes by balancing their effects on glycolysis: p53 restricts the glycolysis activity of senescent cells through several mechanisms [226], while RB upregulates glycolytic genes, resulting in high glycolytic activity [227].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [226]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ide, T., Brown-Endres, L., Chu, K., Ongusaha, P. P., Ohtsuka, T., El-Deiry, W. S., Aaronson, S. A., & Lee, S. W. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.031 · Cited by 92
RetractedOxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441 · cited 1×
“, superoxide dismutase [SOD], glutathione peroxidase [GPx], and GSH) through protective mechanisms.(39) Even though ROS products are part of normal cellular metabolism produced mainly through the mitochondrial respiratory chain and play roles in cell proliferation and survival signaling Figure 2.”
BackgroundThe Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088 · cited 2×
“In cancer cells, AKT activation is also sufficient to drive glycolysis and lactate production and to suppress macromolecular degradation.(31) AMPK is a heterotrimeric protein consisting of 3 subunits—α, β, and γ—and drives the catabolic, energyproducing responses (i.”
BackgroundOn Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820 · cited 1×
“Pyruvate kinase–M2 (PK-M2) is the embryonic splice variant of the rate-limiting enzyme for pyruvate generation that is preferentially expressed in tumor cells and regulates the flux of carbon into ribose-5-phosphate and nucleotide synthesis via phosphotyrosine signaling.(5) Since PK-M2 can regulate the amounts of pyru…”
BackgroundA model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019 · cited 1×
“The p53 protein induces the transcription of the TIGAR gene, which lowers the intracellular concentrations of fructose-2,6-bisphosphate and thus decreases glycolysis and overall levels of intracellular reactive oxygen species (ROS).(8) The decrease in glycolysis allows for entry into the pentose phosphate pathway (PPP…”
Backgroundp53 Has a Direct Apoptogenic Role at the Mitochondria
Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P., & Moll, U. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00050-9 · Cited by 1,777 · cited 1×
“In contrast to the above target gene regulation, p53 can form a complex with the antiapoptotic proteins BCL-X L and PUMA, resulting in cytochrome c release from mitochondria and promotion of mitochondrial outer membrane permeabilization.(14) p53’s role in the regulation of cellular metabolism is complex given the many…”
Backgroundp53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650 · cited 2×
“One way p53 balances the usage of the respiratory and glycolytic pathways is through its downstream mediator, SCO2.(13) SCO2 is critical for regulating a major site of oxygen utilization in the cell, the cytochrome c oxidase (COX) complex.”
BackgroundBrugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384 · cited 1×
“REDD1 overexpression can also downregulate S6K phosphorylation in a TSC1/ TSC2-dependent manner.(33,37) Thus, p53 shuts down IGF-1/AKT and mTOR pathways through the negative regulation of IGF-BP3, PTEN, TSC2, AMPK β1, and sestrins 1 and 2 and thus plays a critical role in cell growth and division, nutritional sensing,…”
Background
Cited by
Items 201–277 of 277
Tharayil, J. S., Kandettu, A., & Chakrabarty, S. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167691 · Cited by 6
Yen, N. T. H., Park, S., Thu, V. T. A., Phat, N. K., Cho, Y., Yoon, S., Shin, J., Kim, D., Oh, J., & Long, N. P. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120801 · Cited by 6
Tracewell, M., Karlin, J., Barnada, S. M., McDuffie, E., Scott, C. P., Barta, J. A., & McMahon, S. B. (2025) · Carcinogenesis · doi:10.1093/carcin/bgaf027 · Cited by 4
Udriştioiu, A., & Nica-Badea, D. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.072 · Cited by 4
Nanomaterials to prevent progression of glioblastoma multiforme from diabetes mellitus
Kuo, Y., & De, S. (2024) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2024.105637 · Cited by 5
Horaţiu-Cristian, P.-V., Stoicea, M. C., Enache, V., Bratu, M. R., Mustăţea, P., Dragut, R., Rusu, E., Ionescu-Tirgoviste, C., & Radulian, G. (2022) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.63.3.06 · Cited by 4
Lynda, E. O., Kingsley, N. E., Obukohwo, O. M., Ben‐Azu, B., Victor, E., Ovuakporaye, S. I., Agbonifo‐Chijiokwu, E., & Oghenetega, O. B. (2023) · JBRA · doi:10.5935/1518-0557.20230062 · Cited by 6
“In line with this issue, the p53 is a sequence-specific transcription factor, which is activated by diverse forms of cellular stress and it is known to mediate the cycle arrest in response to cellular stress (Puzio-Kuter, 2011; Li et al ., 2012).”
BackgroundRole of Tumor Suppressor P53 Family in Glucose Metabolism in Association with Diabetes
Darawadi, B. (2023) · doi:10.23880/accp-16000101 · Cited by 4
Interactions of SARS-CoV-2 with Human Target Cells—A Metabolic View
Eisenreich, W., Leberfing, J., Rudel, T., Heesemann, J., & Goebel, W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189977 · Cited by 5
Hepatoprotective role for ERMP1 in MASLD-driven hepatocarcinogenesis and β-catenin-mutated tumors
Gjorgjieva, M., de Sousa, M. C., Delangre, E., Abegg, D., Maeder, C., Fournier, M., Morin, N., Adibekian, A., Serra, F., Sempoux, C. L., et al. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218427 · Cited by 2
Regulation of Energy Metabolism: An Important Facet of P53 Function
Gilbert, M., Lkhagvasuren, E., Boldbaatar, D., & Magnan, C. (2017) · Central Asian Journal of Medical Sciences · doi:10.24079/cajms.2017.06.002 · Cited by 2
Kharrat, F., Balasan, N., Ura, B., Golino, V., Campiglia, P., Peri, G., Valencic, E., Qaisiya, M., de Moura, R. R., Stazio, M. D., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146621 · Cited by 2
“TP53 inhibits exaggerated glycolysis [76], preventing uncontrolled B cell proliferation.”
Chanda, M., Mekasuwandumrong, C., Wilasrusmee, K. T., Panich, U., & Jirawatnotai, S. (2025) · Hepatoma Research · doi:10.20517/2394-5079.2025.15 · Cited by 6
The Ketogenic Diet as an Adjuvant Therapy for Brain Tumors and Other Cancers
Brooks, K. S., Woolf, E. C., & Scheck, A. C. (2015) · Springer eBooks · doi:10.1007/978-3-319-21461-0_5 · Cited by 2
Tissue-Specific Functions of p53 During Kidney Development
Saifudeen, Z. R. (2017) · Results and problems in cell differentiation · doi:10.1007/978-3-319-51436-9_5 · Cited by 2
“…p53 is a crucial regulator of metabolic homeostasis assisting cells in adapting to adverse conditions by promoting catabolic pathways such as fatty acid oxidation (FAO) in times of nutrient stress by activating expression of multiple genes in the FAO pathway (Zhang et al. 2010; Puzio-Kuter 2011).”
BackgroundSera Anti-P53 Antibody Provides New Information Which Explains the Link Between Diabetes and Cancer
Sauriasari, R., Sekar, A. P., Aisyah, N., Syahdi, R. R., & Matsuura, E. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s213731 · Cited by 3
“Activation of p53 triggers induction of p53 upregulated mediator of apoptosis (PUMA), phosphatase and tensin homolog (PTEN), 6 and its feedback inhibitor murine double minute oncoprotein (MDM2).”
Backgroundp53 and RNA viruses: The tug of war
Pal, A., Tripathi, S. K., Rani, P., Rastogi, M., & Das, S. (2023) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1826 · Cited by 5
“The tumor suppressor p53 is central to metabolic pathways like glucose and fatty acid metabolism (Puzio-Kuter, 2011).”
BackgroundBüyükköroğlu, G., Abbasoğlu, D., & Hızel, C. (2014) · Springer eBooks · doi:10.1007/978-81-322-0843-3_26 · Cited by 4
“Therefore, it seems logical that the restoration of wild-type p53 activity in some tumor types prevents anarchic cell growth or leads to apoptosis [ 71 – 74 ].”
BackgroundSocial isolation induces autophagy in the mouse mammary gland: link to increased mammary cancer risk
Sumis, A. M., Cook, K. L., Andrade, F. O., Hu, R., Kidney, E., Zhan, X., Kim, D., Carney, E., Nguyen, N., Yu, W., et al. (2017) · Endocrine Abstracts · doi:10.1530/endoabs.50.ja3 · Cited by 2
De, S., Banerjee, S., Dey, G., Banerjee, S., & Kumar, S. K. A. (2025) · Journal of Nanotheranostics · doi:10.3390/jnt6010007 · Cited by 1
Mitochondrial proteostasis, unfolded protein response, and its relation to cancer
Kumari, N., Raj, S., & Babuta, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-41553-1.00010-4 · Cited by 1
Quantitation of Immunohistochemistry by Image Analysis Technique
Kayser, K., & Kayser, G. (2015) · Springer eBooks · doi:10.1007/978-1-4939-1516-3_4 · Cited by 1
Ketogenic Diet as Adjunctive Therapy for Malignant Brain Cancer
Scheck, A. C., & Syed, N. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780197501207.003.0015 · Cited by 2
Mitochondrial Energy Metabolism in Carcinogenesis
Kurhaluk, N., & Tkaczenko, H. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_226 · Cited by 2
Temporal expression of Dmp53 and SNAMA isoforms and their relation to genotoxic stress.
Nweke, E. E. (2015) · Cited by 1
Walker, C. M. (2016) · Digital Commons-TMC (Texas Medical Center) · Cited by 1
Gourgiotis, A., Isnard, H., Nonell, A., Aubert, M., Stadelmann, G., Dupont, E., Almahamid, I., Tiang, G., Rao, L., Lukens, W. W., et al. (2013) · Cited by 1
Histone methylation in the freeze-tolerant wood frog, Rana sylvatica
Hawkins, L. J. (2016) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2016-11675 · Cited by 1
Hu, J., Leisegang, M. S., Looso, M., Dumbović, G., Wittig, J., Drekolia, M.-K., Günther, S., John, D., Siragusa, M., Zukunft, S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.05.506654 · Cited by 1
“158 In cancer cells, p53 has been shown to induce the expression of fructose-2,6-bisphosphatase 159 (also known as TP53-induced glycolysis and apoptosis regulator or TIGAR), to inhibit 160 phosphoglycerate mutase (PGM) and repress Glut1 and Glut4 expression.(19) Consistent with the 161 increase in p53 activity in aged…”
BackgroundNatural Product Screen Identifies Asiatic Acid Targeting Mutant p53Preprint
Swargiary, G., Jamal, Q. M. S., Ojha, S. K., Jha, N. K., Singh, K. K., & Mani, S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.23.550189 · Cited by 1
“…the level of cytochrome c oxidase 2 (SCO2), p53 modulator of apoptosis (PUMA), TP53-induced glycolysis and apoptosis regulator (TIGAR), glucose transporter 1 and 4 (GLUT1, GLUT4) (Puzio-Kuter, 2011) and glutaminase 2 (GLS2) but declines the level of phosphoglycerate mutase (PGM) in damaged cells.”
BackgroundMutant p53 binds RNA to drive mitochondrial dysfunctionPreprint
Zhou, W., Long, A., Douglas, C. J., Gallegos, D., Burke, J. M., MacMillan, D. W. C., Hacisuleyman, E., & Seath, C. P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.12.688127 · Cited by 1
Global and specific controls of protein synthesis in hibernators
Pan, P. (2011) · Digital Scholarship - UNLV (University of Nevada Reno) · doi:10.34917/3295694
Hill, C. U. F. K. (2015) · Figshare
Hoffmann, R. F. (2016) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Role of ammonium ions on the modulation of apoptosis in glutamine-starved cells
Abusneina, A. M. (2017) · Lu Zone Ul (Laurentian University)
Understanding p53 structure and targeting mutant p53 for improved cancer therapy
Zhang, Q. (2018) · Figshare
Abdelaziz, M. A. (2018) · Al-Azhar Journal of Pharmaceutical Sciences/Al-Azhar Journal of Pharmaceutical Sciences · doi:10.21608/ajps.2018.6632
Yamakura, M. U. F. (2012)
Experimental Design in Signal Transduction
Gao, W., Cromie, M. M., Wang, Q., Liu, Z., Tang, S., & Miller, J. V. (2019) · Wiley eBooks · doi:10.1002/9781119060208.ch5
Roy, D. (2019) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2019-13752
Transcriptomic Signature of Radiation Response in Li-Fraumeni Syndrome
Sauberli-Stewart, K. (2019) · TSpace (University of Toronto)
The Role of p53 Serine 23 in Insulin Resistance
Nguyen, K. T. (2014) · Digital WPI
Hameed, R. M. A. (2013) · bonndoc (University of Bonn) · Cited by 1
Structural-Functional Diversity of p53 Proteoforms
Naryzhny, S., & Legina, O. K. (2019) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s199075081904005x · Cited by 1
Ketogenic Diet as Adjunctive Therapy for Malignant Brain Cancer
Woolf, E. C., & Scheck, A. C. (2016) · Oxford University Press eBooks · doi:10.1093/med/9780190497996.003.0013
Erratum to: The 2014 Beatson international cancer conference: powering the cancer machine
Kamphorst, J. J., & Murphy, D. J. (2014) · Cancer & Metabolism · doi:10.1186/s40170-014-0127-8
Samec, M., Mazuráková, A., Lučanský, V., Koklesová, L., Péčová, R., Péč, M. J., Golubnitschaja, O., AL-Ishaq, R. K., Čaprnda, M., Gašpar, Ľ., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2273746/v1
Modulation of HSF1 activity by p53 and its impact in cancer therapies
Isermann, T. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9996
Approaches to Study Tumor Metabolism in Mice
Gültekin, Y., Heiden, M. G. V., & Lien, E. C. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041420
Basic and Translational Science in Oncology
Bhatia, D. R., & Gupta, S. (2024) · Springer eBooks · doi:10.1007/978-981-99-3378-5_1
Yuan, H., Chen, C., Li, H., Qu, G., Chen, L., Liu, Y., Zhang, Y., Zhao, Q., Lian, C., 纪爱芳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26675021
Yuan, H., Chen, C., Li, H., Qu, G., Chen, L., Liu, Y., Zhang, Y., Zhao, Q., Lian, C., 纪爱芳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26675012
Yuan, H., Chen, C., Li, H., Qu, G., Chen, L., Liu, Y., Zhang, Y., Zhao, Q., Lian, C., 纪爱芳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26675033
Yuan, H., Chen, C., Li, H., Qu, G., Chen, L., Liu, Y., Zhang, Y., Zhao, Q., Lian, C., 纪爱芳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26675036
Yuan, H., Chen, C., Li, H., Qu, G., Chen, L., Liu, Y., Zhang, Y., Zhao, Q., Lian, C., 纪爱芳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26675030
Yuan, H., Chen, C., Li, H., Qu, G., Chen, L., Liu, Y., Zhang, Y., Zhao, Q., Lian, C., 纪爱芳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26675027
Yuan, H., Chen, C., Li, H., Qu, G., Chen, L., Liu, Y., Zhang, Y., Zhao, Q., Lian, C., 纪爱芳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26675018
Yuan, H., Chen, C., Li, H., Qu, G., Chen, L., Liu, Y., Zhang, Y., Zhao, Q., Lian, C., 纪爱芳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26675039
Yuan, H., Chen, C., Li, H., Qu, G., Chen, L., Liu, Y., Zhang, Y., Zhao, Q., Lian, C., 纪爱芳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26675024
Yuan, H., Chen, C., Li, H., Qu, G., Chen, L., Liu, Y., Zhang, Y., Zhao, Q., Lian, C., 纪爱芳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.26675015
Thabet, N. M., Abdel-Rafei, M. K., El-Sayyad, G. S., Elkodous, M. A., Shaaban, A., Du, Y.-C., Rashed, L. A., & Askar, M. A. (2022) · Figshare · doi:10.6084/m9.figshare.19923234
Yuan, H., Chen, C., Li, H., Qu, G., Chen, L., Liu, Y., Zhang, Y., Zhao, Q., Lian, C., 纪爱芳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.25123897
Yuan, H., Chen, C., Li, H., Qu, G., Chen, L., Liu, Y., Zhang, Y., Zhao, Q., Lian, C., 纪爱芳, et al. (2024) · Figshare · doi:10.6084/m9.figshare.25124062
Study of tumor cell metabolism and its relationship with NK cell-mediated immunotherapy
Krzywińska, E. (2014) · theses.fr (ABES) · doi:10.70675/55685772z0acez4c8bzaf02z3edd2b0ef19f
Immunothérapie et métabolisme tumorale
Benamor, S. B. (2017) · theses.fr (ABES) · doi:10.70675/2e5cbde1zb4faz4320zbd12z0a2ba777228b
The p53/Mdm2 Pathway in Hepatocellular Carcinoma: From Molecular Pathogenesis to Targeted Therapies
Kirkness, K., & Mann, D. A. (2026) · Livers · doi:10.3390/livers6030039
P53 – a new player in the metabolic adaptation of colorectal carcinoma cells under hypoxia
Saoub, S., Metzen, E., Thakur, B. K., Henning, Y., Schild, Y., Leu, T., Fandrey, J., & Wrobeln, A. (2026) · BMC Cancer · doi:10.1186/s12885-026-16184-y
“In addition to TIGAR-mediated con-trol of fructose-2,6-bisphosphate levels and PFK1 activity, p53 also restrains glycolysis through regulators such as PFKFB3 and through inhibition of alternative glucose uptake pathways [43, 44].”
RBBP6 and cancer: from molecular mechanisms to clinical implications
Ubanako, P. N., Nweke, E. E., Nsingwane, Z., Monchusi, B. A., & Penny, C. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1841906 · Cited by 1
“Finally, p53 plays a pivotal role in regulating glucose metabolism through diverse mechanisms (102), and RBBP6 is known to suppress p53 function.”
p53-associated metabolic checkpoint regulation in a tick embryo-derived cell line
Moraes, B., Arcanjo, A. F., Okagawa, T., Nogueira, C. L., Brumana, A., Souza, J. L., Vasconcelos, A. A., Almeida, F. C. L., Pinto, K. G., Filardy, A., et al. (2026) · Insect Biochemistry and Molecular Biology · doi:10.1016/j.ibmb.2026.104633
Chronobiology of Cancer: How Aging Fuels Oncogenesis at the Molecular Level
Singh, A., Misra, A., & Zaheer, S. (2026) · Aging and Cancer · doi:10.1002/aac2.70027
Mutant p53 gains RNA-binding activity to reprogram translation and mitochondrial function
Zhou, W., Long, A., Douglas, C. J., Gallegos, D., Burke, J. M., MacMillan, D. W. C., Hacisuleyman, E., & Seath, C. P. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117856 · Cited by 1
Poursadeghi, F., Razi, M., & Amniattalab, A. (2026) · BioMed Research International · doi:10.1155/bmri/5121993
“The Bcl-2/Bax balance is an important determinant of mitochondrial membrane integrity and cellular susceptibility to apoptosis, whereas p53 can participate in stress-related transcriptional regulation of proapoptotic pathways [16, 18, 22].”
Metadata
- Authors
- Puzio-Kuter, A. M.
- Venue
- Genes & Cancer
- Publisher
- SAGE Publications
- Published
- 2011-04-01
- Volume
- 2
- Issue
- 4
- Pages
- 385-391
- ISSN
- 1947-6019 (ISSN-L)
- 1947-6027
- PMC
- PMC3135642
- OpenAlex
- W2147294934
- Cited by
- 273
- References
- 60
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 20 · 2023: 13 · 2022: 23 · 2021: 21 · 2020: 26 · 2019: 21 · 2018: 21 · 2017: 24 · 2016: 17 · 2015: 18 · 2014: 24 · 2013: 9 · 2012: 14
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Genes & Cancer (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- p53, tumor suppressor, cancer metabolism, aerobic glycolysis, oxidative phosphorylation, metabolic reprogramming, energy metabolism, oxidative stress, DNA damage response, hypoxia, oncogenes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.